← 研踪 PaperTrailarXiv:2611.18458 · v1
When to Trust Simulated Patient Responses:Support-Gated World Models for Vasopressor Decision Support
首次提交 2026-11-14 01:28
版本更新 2026-11-14 01:28
雷达观测 2026-11-16 11:41
摘要
Clinical world models expose language-model agents to predicted patient responses, but simulations can be unreliable for poorly supported treatments or unfamiliar hospitals. We introduce Support-Gated World-Model decision support, a lightweight extension of a propose--simulate--refine agent. A recurrent dynamics ensemble predicts short-horizon physiological responses to documented norepinephrine dose categories, while a behavior model estimates observational action support. The interface withholds predictions with insufficient support or excessive ensemble disagreement and abstains when no candidate qualifies. Evaluation on eICU-CRD includes 70 hospitals and 30,700 decision transitions, with 14 hospitals held out for testing. At 62.0% factual-transition coverage, joint gating yields a MAP mean absolute error of 7.3 mmHg, compared with 9.2 mmHg for random selection at the same coverage. The gated agent achieves 60.0% agreement with recorded actions at 81.0% decision coverage, compared with 55.0% agreement and 99.5% coverage for an ungated ensemble agent. Component ablations show lower factual risk with joint gating than with either gate alone.These results characterize a reliability--coverage trade-off in selective clinical simulation; they do not identify individualized treatment effects or establish improved patient outcomes.
观测到的版本
相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。
v1 · 2026-11-14 01:28 · 最新观测版本
When to Trust Simulated Patient Responses:Support-Gated World Models for Vasopressor Decision Support
Clinical world models expose language-model agents to predicted patient responses, but simulations can be unreliable for poorly supported treatments or unfamiliar hospitals. We introduce Support-Gated World-Model decision support, a lightweight extension of a propose--simulate--refine agent. A recurrent dynamics ensemble predicts short-horizon physiological responses to documented norepinephrine dose categories, while a behavior model estimates observational action support. The interface withholds predictions with insufficient support or excessive ensemble disagreement and abstains when no candidate qualifies. Evaluation on eICU-CRD includes 70 hospitals and 30,700 decision transitions, with 14 hospitals held out for testing. At 62.0% factual-transition coverage, joint gating yields a MAP mean absolute error of 7.3 mmHg, compared with 9.2 mmHg for random selection at the same coverage. The gated agent achieves 60.0% agreement with recorded actions at 81.0% decision coverage, compared with 55.0% agreement and 99.5% coverage for an ungated ensemble agent. Component ablations show lower factual risk with joint gating than with either gate alone.These results characterize a reliability--coverage trade-off in selective clinical simulation; they do not identify individualized treatment effects or establish improved patient outcomes.
查看此版本解读 →查看此版本原文 ↗